Spencer Fane attorney Jeremy Lowe recently presented at the 14th Annual Pharma IPR India Conference, held March 4-6 in Mumbai. The firm was proud to serve as a Silver Partner for the event.
Held at The Westin, Garden City, Mumbai, the conference is a premier forum for exploring new developments and forward-looking ideas in intellectual property, regulatory pathways, and litigation strategies within India’s pharmaceutical sector. Jeremy led the session, What’s Happening with Double Patenting After Allergan, offering valuable insight into this rapidly developing area of law.
At Spencer Fane, Jeremy leads the firm’s Hatch-Waxman and Biologics Litigation group, representing clients as first chair in complex patent trials and appeals. With over 25 years of experience, he is a Fellow of the Litigation Counsel of America, Order of Certus, Barrister – an honor reserved for the top 0.5% of lawyers, judges, and legal scholars.
Learn more about the Pharma IPR India Conference here.